Tag | Content |
---|
EnhancerAtlas ID | HS094-17485 |
Organism | Homo sapiens |
Tissue/cell | hMADS-3 |
Coordinate | chr17:76379430-76381020 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nr2f6(var.2) | MA0728.1 | chr17:76379525-76379540 | TGAACTCCTGACCTC | - | 6.22 | Stat6 | MA0520.1 | chr17:76380455-76380470 | CTTTCTCAGGAAGTG | - | 6.49 | TCF7L2 | MA0523.1 | chr17:76379695-76379709 | TTTCTTTGAACTTT | - | 6.23 |
|
| Number of super-enhancer constituents: 27 | ID | Coordinate | Tissue/cell |
SE_00336 | chr17:76373804-76385436 | Adipose_Nuclei | SE_02571 | chr17:76379071-76381288 | Astrocytes | SE_06227 | chr17:76379121-76383415 | Brain_Hippocampus_Middle | SE_09402 | chr17:76373053-76385593 | CD14 | SE_18476 | chr17:76373745-76385519 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19399 | chr17:76373920-76383558 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_26825 | chr17:76379799-76381358 | Esophagus | SE_29662 | chr17:76379350-76381359 | Fetal_Muscle | SE_31461 | chr17:76379893-76381298 | Gastric | SE_36965 | chr17:76378947-76383059 | HSMMtube | SE_38195 | chr17:76373184-76383376 | HUVEC | SE_39141 | chr17:76379300-76381277 | IMR90 | SE_40802 | chr17:76379606-76381403 | Left_Ventricle | SE_42104 | chr17:76379266-76383425 | Lung | SE_44143 | chr17:76378881-76381467 | NHDF-Ad | SE_44787 | chr17:76378859-76383440 | NHLF | SE_45620 | chr17:76370124-76383364 | Osteoblasts | SE_48690 | chr17:76379872-76381321 | Right_Atrium | SE_50089 | chr17:76379720-76381460 | Sigmoid_Colon | SE_51088 | chr17:76376802-76385058 | Skeletal_Muscle | SE_51835 | chr17:76379486-76381222 | Skeletal_Muscle_Myoblast | SE_52389 | chr17:76379506-76381423 | Small_Intestine | SE_53327 | chr17:76376882-76383569 | Spleen | SE_55689 | chr17:76379458-76381146 | u87 | SE_58926 | chr17:76309354-76389031 | Ly3 | SE_62409 | chr17:76309367-76385525 | Tonsil | SE_63627 | chr17:76379369-76381327 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TCGAGTAGCT GGGATTACAG GCATGTGCCA CCACGCCCAT CTAATTTTGT ATTTTTAGTA 60 GAGACGCGGT TTCTCCATGT TGGTCAGGCT GGTTTTGAAC TCCTGACCTC AGGTGGTCCG 120 CCCACCTCAG CCTCCCAAAG TGCTGGGATT ACAGGGGTGA GCCACCGTGC CCGGCCTAGA 180 CTTTCTTACA TTGTAGTGGC AGGTCACTTG TTCAACGTGT AAGTAGTTTT TACTCTGAGG 240 GACCACCAGA TTTCCAGAAG TTACTTTTCT TTGAACTTTG TGATGGGATT CGGTCTTCCT 300 TACTCTTCAG AGTTTAGTAT AACCATCTCT TCGTTTGTTT ATAGCAGTAT AATGGCTGGG 360 AAGGGGATAT TTAGAATCAA AGCATAGTTT TGCCAAATAA TTCAGATTTG ATTTTGCAGT 420 GAATTAAAAG ATTTACAACG GACTGACTTT CTCAATTGTA GCTTTAAGTG AATATTAATG 480 TGAGTATCCC TGAGCACGTT ATAGTTGGTG ATGAATTAGA CTCAATCAGT TGTCTGCTGG 540 TAGGCAAATA GAACCCAGCC TGGGATTAAA ATGGTCTGAA TGATAATCCC TTTGTAATAG 600 CGTGATCTGA TTTATGTAAA CGGGTCGATT TTGAGGGTGC TGGGAGTCAG GCTGACTGAA 660 GCCCTTTGGA GTCATAGAAC ATGCGATTGG TTCTCGTCAG GCACTTTGAT GTGCCTGGTG 720 CATTTGGCCA CCCAGGCTGT ATTGTGGGTT ATAAATATAT TTTGGATTTC TGGCCCCCAA 780 TGTAATCGAC TTCCTTTTGG CTAAGCCAAG GGGAGAGTCA TCTAGTCAGC ATGTAGCTGC 840 ATGCTGGCAG CCTGGGCCTC TCGTGCCGGA CTTGTTATGG GAGTTCAGCA GGCCGTTGGT 900 CTTTTGTAAC CTACGGGAAT CCACACTCAT TTCCCTTACT CGGGGTTAGG TCTTGCATTA 960 GTCAGGAAGG GCCGCCTGCT GCCAGGGTTG CAGGAAGTAC GGTACCTTCT TGTAGTTTCT 1020 GGAGCCTTTC TCAGGAAGTG TTATGACTGT TGCTTTTTCT CATCAGTTCA CTTTTTTACA 1080 TTTAAATATC TGTGACTGAG AGGGTAGGGT GAGTTGTTCT CAAAAAGTAG TTTCTGAAAA 1140 TATTGCAATC CAGAGAGCTC AGTTTCTTTT AAAAACTTCT TTTTTCATGG TTTTGTACAG 1200 ATTTGGATGG GCTCCAGGCC ACAGAGTCTG TACCGTGAAT GTACCTTACG GTTAAAGAAG 1260 GGCCCCTGGA CCTTCAGACC ACGCCTCTGA GGGACACTGA ATTACCGACC TGTGTTTGGT 1320 ATGGAGAGCG CAACTTCTGC CCTGTTCAGT GAGGACAGCC CTCCAGCTTT ACCGTACTCT 1380 TTCATCAAAG TCCTACATAC CCTGTTTTGA AAAAACCCCA AGAAGTTGGC CTGTTACATG 1440 TGTCCCATTG GTAGTGGGTG ACAGTCAGTA CTGCAGCTCT AGGGGGAAAC ACGTGTTCTC 1500 TGACACCGGG AGAAGATGTG GAAGGGACGT CTAAAGGTGC AGTGTAGACC GCGGTGTAAT 1560 TCCCTGGTGT TTGCTTGTCT TCAGTGGCAT 1590
|